Company intelligence / Profile preview

Huakang Biomedical

Shenzhen, Guangdong, Chinahuakangbiomedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Huakang Biomedical is a leading Chinese developer and manufacturer of in vitro diagnostic reagents with a particular focus on male fertility testing. The company holds a significant market share in China’s male fertility IVD sector and has the largest number of registered products in this category as of recent years. Its product portfolio also includes parasite antibody detection reagents—one being among only two CFDA-approved liver fluke tests—and an EBV antibody test reagent. Products are sold to hospitals and medical institutions across China via direct sales and distributors.

Therapeutic areas: Infectious DiseasesMen's Health
Modalities: In vitro diagnostic reagent
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Huakang Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huakang Biomedical.

Explore the full profile